121 related articles for article (PubMed ID: 27883274)
1. Impact of the Chronic Omega-3 Fatty Acids Supplementation in Hemiparkinsonism Model Induced by 6-Hydroxydopamine in Rats.
Barros AS; Crispim RYG; Cavalcanti JU; Souza RB; Lemos JC; Cristino Filho G; Bezerra MM; Pinheiro TFM; de Vasconcelos SMM; Macêdo DS; de Barros Viana GS; Aguiar LMV
Basic Clin Pharmacol Toxicol; 2017 Jun; 120(6):523-531. PubMed ID: 27883274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
Delattre AM; Kiss A; Szawka RE; Anselmo-Franci JA; Bagatini PB; Xavier LL; Rigon P; Achaval M; Iagher F; de David C; Marroni NA; Ferraz AC
Neurosci Res; 2010 Mar; 66(3):256-64. PubMed ID: 19941911
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
4. Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson's Disease Model.
Delattre AM; Carabelli B; Mori MA; Kempe PG; Rizzo de Souza LE; Zanata SM; Machado RB; Suchecki D; Andrade da Costa BLS; Lima MMS; Ferraz AC
Mol Neurobiol; 2017 Apr; 54(3):2090-2106. PubMed ID: 26924316
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
Hernando S; Requejo C; Herran E; Ruiz-Ortega JA; Morera-Herreras T; Lafuente JV; Ugedo L; Gainza E; Pedraz JL; Igartua M; Hernandez RM
Neurobiol Dis; 2019 Jan; 121():252-262. PubMed ID: 30296616
[TBL] [Abstract][Full Text] [Related]
6. Eugenol and its association with levodopa in 6-hydroxydopamine-induced hemiparkinsonian rats: Behavioural and neurochemical alterations.
Moreira Vasconcelos CF; da Cunha Ferreira NM; Hardy Lima Pontes N; de Sousa Dos Reis TD; Basto Souza R; Aragão Catunda Junior FE; Vasconcelos Aguiar LM; Maranguape Silva da Cunha R
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):287-302. PubMed ID: 32353201
[TBL] [Abstract][Full Text] [Related]
7. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
[TBL] [Abstract][Full Text] [Related]
8. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
9. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
11. L-linalool exerts a neuroprotective action on hemiparkinsonian rats.
de Lucena JD; Gadelha-Filho CVJ; da Costa RO; de Araújo DP; Lima FAV; Neves KRT; de Barros Viana GS
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1077-1088. PubMed ID: 31938809
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
13. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
14. Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Alleviates Doxorubicin-Induced Depressive-Like Behaviors and Neurotoxicity in Rats: Involvement of Oxidative Stress and Neuroinflammation.
Wu YQ; Dang RL; Tang MM; Cai HL; Li HD; Liao DH; He X; Cao LJ; Xue Y; Jiang P
Nutrients; 2016 Apr; 8(4):243. PubMed ID: 27120616
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
Haghdoost-Yazdi H; Piri H; Faraji A; Fraidouni N; Dargahi T; Mahmudi M; Alipour Heidari M
Neurol Res; 2016 Apr; 38(4):294-300. PubMed ID: 27098232
[TBL] [Abstract][Full Text] [Related]
16. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
Ozsoy O; Yildirim FB; Ogut E; Kaya Y; Tanriover G; Parlak H; Agar A; Aslan M
Free Radic Res; 2015; 49(8):1004-14. PubMed ID: 25791066
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.
Morroni F; Sita G; Tarozzi A; Cantelli-Forti G; Hrelia P
Brain Res; 2014 Nov; 1589():93-104. PubMed ID: 25257035
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.
Souza RB; Frota AF; Sousa RS; Cezario NA; Santos TB; Souza LM; Coura CO; Monteiro VS; Cristino Filho G; Vasconcelos SM; da Cunha RM; Aguiar LM; Benevides NM
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):159-170. PubMed ID: 27612165
[TBL] [Abstract][Full Text] [Related]
20. URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats.
Maya-López M; Ruiz-Contreras HA; de Jesús Negrete-Ruíz M; Martínez-Sánchez JE; Benítez-Valenzuela J; Colín-González AL; Villeda-Hernández J; Sánchez-Chapul L; Parra-Cid C; Rangel-López E; Santamaría A
Biomed Pharmacother; 2017 Apr; 88():745-753. PubMed ID: 28157650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
